Skip to content
Home/Companies/MedTech/Orliman

Orliman

MedTech·Spain·Exited 2017·Held 2yr
Entry
2015
Hold
2yr
Exit
2017

Who owns Orliman?

Orliman was owned by Magnum Capital through Magnum Capital II (2015 vintage) from 2015 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Magnum Capital
Investor
Magnum Capital
Magnum Capital II · 2015 · Buyout

Key facts

HQSpain
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Magnum Capital II

Other portfolio companies in the same fund.

Miranza
Miranza
Exited 2022
HealthcareSpain· 2019
to
Aire Networks
Exited 2022
TelecomSpain· 2018
to
Indiba
Indiba
Exited 2022
MedTechSpain· 2018
to
Itasa
Itasa
Exited 2021
IndustrialsSpain· 2018
to
Lexer
Lexer
Exited 2021
LegalTechSpain· 2018
to
ROQ
Active
IndustrialsPortugal· 2018

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Orliman

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Orliman.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue